ストックスクリーナーアプリを入手
4.0002
0.24%
-0.0098
前日終値:
$4.01
開ける：
$3.99
24時間の取引高:
3.45M
Relative Volume:
2.32
時価総額：
$397.81M
収益：
$58.36M
当期純損益:
$-25.72M
株価収益率:
-10.99
EPS:
-0.3641
ネットキャッシュフロー:
$-24.91M
1週間 パフォーマンス:
+1.79%
1か月 パフォーマンス:
-0.74%
6か月 パフォーマンス:
+20.49%
1年 パフォーマンス:
+3.63%
1日の値動き範囲:
$3.83
$4.1556
1週間の範囲:
$3.6903
$4.27
52週間の値動き範囲:
$2.12
$5.80
Aquestive Therapeutics Inc Stock (AQST) Company Profile
名前
Aquestive Therapeutics Inc
セクター
電話
908-941-1900
住所
30 TECHNOLOGY DRIVE, WARREN, NJ
AQST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.005 | 375.46M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
152.80 | 66.38B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.79 | 46.20B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.696 | 42.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.61 | 19.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
308.66 | 13.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2024-12-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Piper Sandler | Overweight |
| 2024-03-28 | 開始されました | Raymond James | Outperform |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-04-22 | 開始されました | H.C. Wainwright | Buy |
| 2019-01-03 | 開始されました | Lake Street | Buy |
| 2018-08-20 | 開始されました | JMP Securities | Mkt Outperform |
| 2018-08-20 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Aquestive Therapeutics Inc (AQST) 最新ニュース
Aquestive’s $85M offering and royalty deal; Basilea gets rights to UTI drug candidate - Endpoints News
Aquestive Therapeutics stock rises after securing $75 million funding deal By Investing.com - Investing.com Australia
Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail - Stocktwits
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Have Been Cutting Their Estimates - 富途牛牛
Aquestive Therapeutics Prices $85 Million Common Stock Offering - MarketScreener
Aquestive Therapeutics rises after pricing $85M stock offering - MSN
Aquestive Therapeutics prices $85 million public offering By Investing.com - Investing.com Canada
Aquestive Therapeutics Secures $75 Million Funding Agreement with RTW - MarketScreener
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock - GlobeNewswire
Aquestive Secures $85M Backing to Launch Novel Sublingual Film for Severe Allergic Reactions - Stock Titan
First-Ever Oral Emergency Allergy Treatment Gets $75M Boost from RTW Investment - Stock Titan
Aquestive Therapeutics Inc. Forms Bullish Flag — Upside AheadTrend Reversal & Scalable Portfolio Growth Ideas - 선데이타임즈
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2025 Earnings Call Transcript - Insider Monkey
Aquestive Therapeutics Inc (AQST) Q2 2025 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
Aquestive Therapeutics Inc. Rebound Backed by Sentiment ShiftJuly 2025 Intraday Action & High Accuracy Swing Trade Signals - 선데이타임즈
Aquestive Therapeutics Reports Q2 2025 Financial Results - TipRanks
Aquestive Therapeutics Q2 2025 Earnings: What to Expect - AInvest
Aquestive's Q2 2025 Earnings Call: Navigating Contradictions in FDA Approval, Launch Readiness, and Market Strategy - AInvest
Aquestive Therapeutics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:AQST) - Seeking Alpha
Transcript : Aquestive Therapeutics, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Earnings call transcript: Aquestive Therapeutics Q2 2025 sees EPS beat, revenue miss - Investing.com UK
Aquestive Therapeutics Q2 2023 Earnings Report & AnalysisNews and Statistics - IndexBox
Aquestive 2025 Q2 Earnings Net Loss Widens Sharply - AInvest
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates - MSN
Aquestive Therapeutics: Q2 Earnings Snapshot - Stamford Advocate
Aquestive Therapeutics Q2 Earnings Miss Estimates, Revenue Down 50% YoY - AInvest
Compared to Estimates, Aquestive Therapeutics (AQST) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Aquestive Therapeutics shares rise 2.33% after-hours after FDA accepts NDA submission for Anaphylm™. - AInvest
Aquestive Therapeutics: Positioning for a Game-Changing 2026 Launch of Anaphylm - AInvest
Aquestive Q2 2025 slides: Anaphylm advances toward FDA decision, cash burn continues By Investing.com - Investing.com South Africa
Aquestive Q2 2025 slides: Anaphylm advances toward FDA decision, cash burn continues - Investing.com
Aquestive Therapeutics earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada
Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Aquestive Therapeutics Inc (AQST) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Aquestive Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
Aquestive Therapeutics Inc Q2 2025 Earnings Preview: Revenue Expectations Fall to $11.32M, Earnings at -$0.17 per Share - AInvest
Aquestive Therapeutics Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Uncovering Potential: Aquestive Therapeutics's Earnings Preview - 富途牛牛
Aquestive Therapeutics Inc (AQST) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
What caused AQST's surprising Q2 2024 EPS surge? - AInvest
Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET - The Manila Times
Aquestive Therapeutics Q2 2025 Earnings Release Date Set for August 11 | AQST Stock News - Stock Titan
Why is Aquestive Therapeutics Inc. stock attracting strong analyst attentionInvest confidently with real-time data analysis - Jammu Links News
What is the risk reward ratio of investing in Aquestive Therapeutics Inc. stockTrack top-performing stocks in real-time - Jammu Links News
What makes Aquestive Therapeutics Inc. stock price move sharplyAccelerated investment success - Jammu Links News
How does Aquestive Therapeutics Inc. compare to its industry peersCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Aquestive Therapeutics Inc. stockDiscover breakthrough investment opportunities - Jammu Links News
What drives Aquestive Therapeutics Inc. stock priceCapitalize on market momentum for maximum gains - Jammu Links News
What is the dividend policy of Aquestive Therapeutics Inc. stockInvest confidently with data-driven strategies - Jammu Links News
What analysts say about Aquestive Therapeutics Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
How strong is Aquestive Therapeutics Inc. company’s balance sheetExceptional market performance - Jammu Links News
Aquestive Therapeutics Inc (AQST) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
1.39%
大文字化:
|
ボリューム (24 時間):